Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -2.78% | 240.83 | 1.3% | $820.70m | |
| MRNA | Moderna, Inc. | -6.05% | 65.64 | 0.0% | $717.07m | |
| NVAX | Novavax, Inc. | -3.00% | 105.11 | 96.5% | $673.14m | |
| IMMU | Immunomedics, Inc. | -0.19% | 85.37 | 11.0% | $599.85m | |
| GILD | Gilead Sciences, Inc. | -2.06% | 63.71 | 1.0% | $586.80m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.22% | 548.47 | 2.7% | $439.67m | |
| BIIB | Biogen, Inc. | -2.56% | 267.46 | 1.6% | $324.45m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.02% | 260.04 | 1.9% | $322.54m | |
| ILMN | Illumina, Inc. | -8.28% | 271.02 | 3.5% | $287.16m | |
| SRNE | Sorrento Therapeutics, Inc. | -4.09% | 9.04 | 1.5% | $263.45m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -2.88% | 110.45 | 2.0% | $258.88m | |
| MNTA | Momenta Pharmaceuticals, Inc. | 0.15% | 52.34 | 3.0% | $237.70m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -2.56% | 77.35 | 4.3% | $233.37m | |
| VXRT | Vaxart, Inc. | 3.95% | 8.55 | 0.0% | $222.15m | |
| SGEN | Seattle Genetics, Inc. | -1.05% | 179.05 | 6.0% | $192.12m |
Company Profile
INmune Bio, Inc. focuses on controlling components of the immune system to activate an immune response against cancer and Alzheimer’s disease. Its product pipeline INKMUNE-Cancer, INB03-Cancer, XPRO1595-Alzheimer, and LIVNATE. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.